Skip to main content
Top
Published in: Breast Cancer 2/2018

01-03-2018 | Original Article

Local anesthetic delivery via surgical drain provides improved pain control versus direct skin infiltration following axillary node dissection for breast cancer

Authors: Muska Khpal, James R. C. Miller, Zika Petrovic, Delilah Hassanally

Published in: Breast Cancer | Issue 2/2018

Login to get access

Abstract

Background

Axillary node dissection has a central role in the surgical management of breast cancer; however, it is associated with a significant risk of lymphoedema and chronic pain. Peri-operative administration of local anesthesia reduces acute and persistent post-surgical pain, but there is currently no consensus on the optimal method of local anesthetic delivery.

Methods

Patients undergoing axillary dissection for breast cancer were randomly assigned to receive a one-off dose of levobupivacaine 0.5% (up to 2 mg/kg) following surgery, either via the surgical drain or by direct skin infiltration. Post-operative pain control at rest and on shoulder abduction was assessed using a numerical rating scale. Total analgesia consumption 48 h after surgery was also recorded.

Results

Pain scores were significantly lower when local anesthesia was administered via surgical drain at both 3 and 12 h after surgery; this trend extended to 24 h post-operatively. However, pain scores on shoulder abduction did not differ at the 12 or 24 h time points. No differences were found in the total analgesia consumption or length of hospital stay between treatment groups.

Discussion

This study demonstrates that local anesthetic delivery via a surgical drain provides improved pain control compared to direct skin infiltration following axillary node dissection. This is likely to be important for the management of acute pain in the immediate post-operative period; however, further studies may be required to validate this in specific patient subgroups, e.g., breast-conserving surgery versus mastectomy.
Literature
1.
go back to reference Tryggvadóttir L, Gislum M, Bray F, Klint A, Hakulinen T, Storm HH, et al. Trends in the survival of patients diagnosed with breast cancer in the Nordic countries 1964–2003 followed up to the end of 2006. Acta Oncol. 2010;49:624–31.CrossRefPubMed Tryggvadóttir L, Gislum M, Bray F, Klint A, Hakulinen T, Storm HH, et al. Trends in the survival of patients diagnosed with breast cancer in the Nordic countries 1964–2003 followed up to the end of 2006. Acta Oncol. 2010;49:624–31.CrossRefPubMed
2.
go back to reference Mejdahl MK, Andersen KG, Gärtner R, Kroman N, Kehlet H. Persistent pain and sensory disturbances after treatment for breast cancer: 6 years nationwide follow-up study. BMJ. 2013;346:f1865.CrossRefPubMed Mejdahl MK, Andersen KG, Gärtner R, Kroman N, Kehlet H. Persistent pain and sensory disturbances after treatment for breast cancer: 6 years nationwide follow-up study. BMJ. 2013;346:f1865.CrossRefPubMed
3.
go back to reference Smith HS, Wu SX. Persistent pain after breast cancer treatment. Ann Palliat Med. 2012;1:182–94.PubMed Smith HS, Wu SX. Persistent pain after breast cancer treatment. Ann Palliat Med. 2012;1:182–94.PubMed
4.
go back to reference Stubblefield MD, Custodio CM. Upper-extremity pain disorders in breast cancer. Arch Phys Med Rehabil. 2006;87:S96–9.CrossRefPubMed Stubblefield MD, Custodio CM. Upper-extremity pain disorders in breast cancer. Arch Phys Med Rehabil. 2006;87:S96–9.CrossRefPubMed
5.
go back to reference Jung BF, Ahrendt GM, Oaklander AL, Dworkin RH. Neuropathic pain following breast cancer surgery: proposed classification and research update. Pain. 2003;104:1–13.CrossRefPubMed Jung BF, Ahrendt GM, Oaklander AL, Dworkin RH. Neuropathic pain following breast cancer surgery: proposed classification and research update. Pain. 2003;104:1–13.CrossRefPubMed
6.
go back to reference Andersen KG, Duriaud HM, Jensen HE, Kroman N, Kehlet H. Predictive factors for the development of persistent pain after breast cancer surgery. Pain. 2015;156:2413–22.CrossRefPubMed Andersen KG, Duriaud HM, Jensen HE, Kroman N, Kehlet H. Predictive factors for the development of persistent pain after breast cancer surgery. Pain. 2015;156:2413–22.CrossRefPubMed
7.
go back to reference Belfer I, Schreiber KL, Shaffer JR, Shnol H, Blaney K, Morando A, et al. Persistent postmastectomy pain in breast cancer survivors: analysis of clinical, demographic, and psychosocial factors. J Pain. 2013;14:1185–95.CrossRefPubMed Belfer I, Schreiber KL, Shaffer JR, Shnol H, Blaney K, Morando A, et al. Persistent postmastectomy pain in breast cancer survivors: analysis of clinical, demographic, and psychosocial factors. J Pain. 2013;14:1185–95.CrossRefPubMed
8.
go back to reference Tasmuth T, Kataja M, Blomqvist C, von Smitten K, Kalso E. Treatment-related factors predisposing to chronic pain in patients with breast cancer—a multivariate approach. Acta Oncol. 1997;36:625–30.CrossRefPubMed Tasmuth T, Kataja M, Blomqvist C, von Smitten K, Kalso E. Treatment-related factors predisposing to chronic pain in patients with breast cancer—a multivariate approach. Acta Oncol. 1997;36:625–30.CrossRefPubMed
9.
go back to reference Hickey OT, Burke SM, Hafeez P, Mudrakouski AL, Hayes ID, Shorten GD. Severity of acute pain after breast surgery is associated with the likelihood of subsequently developing persistent pain. Clin J Pain. 2010;26:556–60.CrossRefPubMed Hickey OT, Burke SM, Hafeez P, Mudrakouski AL, Hayes ID, Shorten GD. Severity of acute pain after breast surgery is associated with the likelihood of subsequently developing persistent pain. Clin J Pain. 2010;26:556–60.CrossRefPubMed
10.
go back to reference Fassoulaki A, Melemeni A, Staikou C, Triga A, Sarantopoulos C. Acute postoperative pain predicts chronic pain and long-term analgesic requirements after breast surgery for cancer. Acta Anaesthesiol Belg. 2008;59:241–8.PubMed Fassoulaki A, Melemeni A, Staikou C, Triga A, Sarantopoulos C. Acute postoperative pain predicts chronic pain and long-term analgesic requirements after breast surgery for cancer. Acta Anaesthesiol Belg. 2008;59:241–8.PubMed
11.
go back to reference Fassoulaki A, Triga A, Melemeni A, Sarantopoulos C. Multimodal analgesia with gabapentin and local anesthetics prevents acute and chronic pain after breast surgery for cancer. Anesth Analg. 2005;101:1427–32.CrossRefPubMed Fassoulaki A, Triga A, Melemeni A, Sarantopoulos C. Multimodal analgesia with gabapentin and local anesthetics prevents acute and chronic pain after breast surgery for cancer. Anesth Analg. 2005;101:1427–32.CrossRefPubMed
12.
go back to reference Abdelsattar JM, Boughey JC, Fahy AS, Jakub JW, Farley DR, Hieken TJ, et al. Comparative study of liposomal bupivacaine versus paravertebral block for pain control following mastectomy with immediate tissue expander reconstruction. Ann Surg Oncol. 2016;23:465–70.CrossRefPubMed Abdelsattar JM, Boughey JC, Fahy AS, Jakub JW, Farley DR, Hieken TJ, et al. Comparative study of liposomal bupivacaine versus paravertebral block for pain control following mastectomy with immediate tissue expander reconstruction. Ann Surg Oncol. 2016;23:465–70.CrossRefPubMed
13.
go back to reference Andreae MH, Andreae DA. Local anesthetics and regional anesthesia for preventing chronic pain after surgery. Cochrane Database Syst Rev. 2012;10:CD007105.PubMedPubMedCentral Andreae MH, Andreae DA. Local anesthetics and regional anesthesia for preventing chronic pain after surgery. Cochrane Database Syst Rev. 2012;10:CD007105.PubMedPubMedCentral
14.
go back to reference Vigneau A, Salengro A, Berger J, Rouzier R, Barranger E, Marret E, et al. A double blind randomized trial of wound infiltration with ropivacaine after breast cancer surgery with axillary nodes dissection. BMC Anesthesiol. 2011;11:23.CrossRefPubMedPubMedCentral Vigneau A, Salengro A, Berger J, Rouzier R, Barranger E, Marret E, et al. A double blind randomized trial of wound infiltration with ropivacaine after breast cancer surgery with axillary nodes dissection. BMC Anesthesiol. 2011;11:23.CrossRefPubMedPubMedCentral
15.
go back to reference Lu TJ, Chen JH, Hsu HM, Wu CT, Yu JC. Efficiency of infiltration with bupivacain after modified radical mastectomy. Acta Chir Belg. 2011;111:360–3.CrossRefPubMed Lu TJ, Chen JH, Hsu HM, Wu CT, Yu JC. Efficiency of infiltration with bupivacain after modified radical mastectomy. Acta Chir Belg. 2011;111:360–3.CrossRefPubMed
16.
go back to reference Albi-Feldzer A, Mouret-Fourme EE, Hamouda S, Motamed C, Dubois PY, Jouanneau L, et al. A double-blind randomized trial of wound and intercostal space infiltration with ropivacaine during breast cancer surgery: effects on chronic postoperative pain. Anesthesiology. 2013;118:318–26.CrossRefPubMed Albi-Feldzer A, Mouret-Fourme EE, Hamouda S, Motamed C, Dubois PY, Jouanneau L, et al. A double-blind randomized trial of wound and intercostal space infiltration with ropivacaine during breast cancer surgery: effects on chronic postoperative pain. Anesthesiology. 2013;118:318–26.CrossRefPubMed
17.
go back to reference Schulz KF, Altman DG, Moher D, CONSORT Group. CONSORT statement: updated guidelines for reporting parallel group randomised trials. BMJ. 2010;2010(340):c332.CrossRef Schulz KF, Altman DG, Moher D, CONSORT Group. CONSORT statement: updated guidelines for reporting parallel group randomised trials. BMJ. 2010;2010(340):c332.CrossRef
18.
go back to reference Wong DL, Baker CM. Pain in children: comparison of assessment scales. Pediatr Nurs. 1988;14:9–17.PubMed Wong DL, Baker CM. Pain in children: comparison of assessment scales. Pediatr Nurs. 1988;14:9–17.PubMed
19.
go back to reference Perkins FM, Kehlet H. Chronic pain as an outcome of surgery. A review of predictive factors. Anesthesiology. 2000;93:1123–33.CrossRefPubMed Perkins FM, Kehlet H. Chronic pain as an outcome of surgery. A review of predictive factors. Anesthesiology. 2000;93:1123–33.CrossRefPubMed
20.
go back to reference Staats PS. The effect of pain on survival. Anesthesiol Clin N Am. 2003;21:825–33.CrossRef Staats PS. The effect of pain on survival. Anesthesiol Clin N Am. 2003;21:825–33.CrossRef
Metadata
Title
Local anesthetic delivery via surgical drain provides improved pain control versus direct skin infiltration following axillary node dissection for breast cancer
Authors
Muska Khpal
James R. C. Miller
Zika Petrovic
Delilah Hassanally
Publication date
01-03-2018
Publisher
Springer Japan
Published in
Breast Cancer / Issue 2/2018
Print ISSN: 1340-6868
Electronic ISSN: 1880-4233
DOI
https://doi.org/10.1007/s12282-017-0810-z

Other articles of this Issue 2/2018

Breast Cancer 2/2018 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine